BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Creeden JF, Alganem K, Imami AS, Henkel ND, Brunicardi FC, Liu SH, Shukla R, Tomar T, Naji F, McCullumsmith RE. Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia. Int J Mol Sci 2020;21:E8823. [PMID: 33233470 DOI: 10.3390/ijms21228823] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Tucker JA, Martin MP. Recent Advances in Kinase Drug Discovery Part I: The Editors' Take. Int J Mol Sci 2021;22:7560. [PMID: 34299180 DOI: 10.3390/ijms22147560] [Reference Citation Analysis]
2 Ünlü A, Duman-Özdamar ZE, Çaloğlu B, Binay B. Enzymes for Efficient CO2 Conversion. Protein J 2021;40:489-503. [PMID: 34100161 DOI: 10.1007/s10930-021-10007-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Richardson D, Azad MG, Afroz R, Richardson V, Dharmasivam M. Thiosemicarbazones reprogram pancreatic cancer bidirectional oncogenic signaling between cancer cells and stellate cells to suppress desmoplasia. Future Medicinal Chemistry. [DOI: 10.4155/fmc-2022-0050] [Reference Citation Analysis]
4 Creeden JF, Alganem K, Imami AS, Brunicardi FC, Liu SH, Shukla R, Tomar T, Naji F, McCullumsmith RE. Kinome Array Profiling of Patient-Derived Pancreatic Ductal Adenocarcinoma Identifies Differentially Active Protein Tyrosine Kinases. Int J Mol Sci 2020;21:E8679. [PMID: 33213062 DOI: 10.3390/ijms21228679] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
5 Creeden JF, Kipp ZA, Xu M, Flight RM, Moseley HNB, Martinez GJ, Lee WH, Alganem K, Imami AS, McMullen MR, Roychowdhury S, Nawabi AM, Hipp JA, Softic S, Weinman SA, McCullumsmith R, Nagy LE, Hinds TD Jr. Hepatic kinome atlas: An in-depth identification of kinase pathways in liver fibrosis of humans and rodents. Hepatology 2022. [PMID: 35313030 DOI: 10.1002/hep.32467] [Reference Citation Analysis]
6 Cheng F, Li Q, Wang J, Wang L, Li W, Zeng F, Zhang Z. HCK is a Potential Prognostic Biomarker that Correlates with Immune Cell Infiltration in Acute Myeloid Leukemia. Disease Markers 2022;2022:1-22. [DOI: 10.1155/2022/3199589] [Reference Citation Analysis]